Stealth Liposomes Encapsulating a Potent ACAT1/SOAT1 Inhibitor F12511: Pharmacokinetic, Biodistribution, and Toxicity Studies in Wild-Type Mice and Efficacy Studies in Triple Transgenic Alzheimer's Disease Mice. 2023

Adrianna L De La Torre, and Thao N Huynh, and Catherine C Y Chang, and Darcy B Pooler, and Dylan B Ness, and Lionel D Lewis, and Sanjana Pannem, and Yichen Feng, and Kimberley S Samkoe, and William F Hickey, and Ta Yuan Chang
Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.

Cholesterol is essential for cellular function and is stored as cholesteryl esters (CEs). CEs biosynthesis is catalyzed by the enzymes acyl-CoA:cholesterol acyltransferase 1 and 2 (ACAT1 and ACAT2), with ACAT1 being the primary isoenzyme in most cells in humans. In Alzheimer's Disease, CEs accumulate in vulnerable brain regions. Therefore, ACATs may be promising targets for treating AD. F12511 is a high-affinity ACAT1 inhibitor that has passed phase 1 safety tests for antiatherosclerosis. Previously, we developed a nanoparticle system to encapsulate a large concentration of F12511 into a stealth liposome (DSPE-PEG2000 with phosphatidylcholine). Here, we injected the nanoparticle encapsulated F12511 (nanoparticle F) intravenously (IV) in wild-type mice and performed an HPLC/MS/MS analysis and ACAT enzyme activity measurement. The results demonstrated that F12511 was present within the mouse brain after a single IV but did not overaccumulate in the brain or other tissues after repeated IVs. A histological examination showed that F12511 did not cause overt neurological or systemic toxicity. We then showed that a 2-week IV delivery of nanoparticle F to aging 3xTg AD mice ameliorated amyloidopathy, reduced hyperphosphorylated tau and nonphosphorylated tau, and reduced neuroinflammation. This work lays the foundation for nanoparticle F to be used as a possible therapy for AD and other neurodegenerative diseases.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000101 Acetyl-CoA C-Acetyltransferase An enzyme that catalyzes the formation of acetoacetyl-CoA from two molecules of ACETYL COA. Some enzymes called thiolase or thiolase-I have referred to this activity or to the activity of ACETYL-COA C-ACYLTRANSFERASE. Acetoacetyl CoA Thiolase,Acetyl Coenzyme A Acetyltransferase,Acetyl-CoA Acetyltransferase,Acetyl CoA Acetyltransferase,Acetyl CoA C Acetyltransferase,Acetyltransferase, Acetyl-CoA,C-Acetyltransferase, Acetyl-CoA,CoA Thiolase, Acetoacetyl,Thiolase, Acetoacetyl CoA
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem

Related Publications

Adrianna L De La Torre, and Thao N Huynh, and Catherine C Y Chang, and Darcy B Pooler, and Dylan B Ness, and Lionel D Lewis, and Sanjana Pannem, and Yichen Feng, and Kimberley S Samkoe, and William F Hickey, and Ta Yuan Chang
January 2015, Future medicinal chemistry,
Adrianna L De La Torre, and Thao N Huynh, and Catherine C Y Chang, and Darcy B Pooler, and Dylan B Ness, and Lionel D Lewis, and Sanjana Pannem, and Yichen Feng, and Kimberley S Samkoe, and William F Hickey, and Ta Yuan Chang
March 1997, Biochimica et biophysica acta,
Adrianna L De La Torre, and Thao N Huynh, and Catherine C Y Chang, and Darcy B Pooler, and Dylan B Ness, and Lionel D Lewis, and Sanjana Pannem, and Yichen Feng, and Kimberley S Samkoe, and William F Hickey, and Ta Yuan Chang
February 2022, Journal of neuroscience methods,
Adrianna L De La Torre, and Thao N Huynh, and Catherine C Y Chang, and Darcy B Pooler, and Dylan B Ness, and Lionel D Lewis, and Sanjana Pannem, and Yichen Feng, and Kimberley S Samkoe, and William F Hickey, and Ta Yuan Chang
October 2012, Journal of young pharmacists : JYP,
Adrianna L De La Torre, and Thao N Huynh, and Catherine C Y Chang, and Darcy B Pooler, and Dylan B Ness, and Lionel D Lewis, and Sanjana Pannem, and Yichen Feng, and Kimberley S Samkoe, and William F Hickey, and Ta Yuan Chang
January 2014, Revista espanola de geriatria y gerontologia,
Adrianna L De La Torre, and Thao N Huynh, and Catherine C Y Chang, and Darcy B Pooler, and Dylan B Ness, and Lionel D Lewis, and Sanjana Pannem, and Yichen Feng, and Kimberley S Samkoe, and William F Hickey, and Ta Yuan Chang
April 2018, Scientific reports,
Adrianna L De La Torre, and Thao N Huynh, and Catherine C Y Chang, and Darcy B Pooler, and Dylan B Ness, and Lionel D Lewis, and Sanjana Pannem, and Yichen Feng, and Kimberley S Samkoe, and William F Hickey, and Ta Yuan Chang
December 2020, Cell death & disease,
Adrianna L De La Torre, and Thao N Huynh, and Catherine C Y Chang, and Darcy B Pooler, and Dylan B Ness, and Lionel D Lewis, and Sanjana Pannem, and Yichen Feng, and Kimberley S Samkoe, and William F Hickey, and Ta Yuan Chang
June 2019, Molecules (Basel, Switzerland),
Adrianna L De La Torre, and Thao N Huynh, and Catherine C Y Chang, and Darcy B Pooler, and Dylan B Ness, and Lionel D Lewis, and Sanjana Pannem, and Yichen Feng, and Kimberley S Samkoe, and William F Hickey, and Ta Yuan Chang
January 2012, Journal of drug targeting,
Adrianna L De La Torre, and Thao N Huynh, and Catherine C Y Chang, and Darcy B Pooler, and Dylan B Ness, and Lionel D Lewis, and Sanjana Pannem, and Yichen Feng, and Kimberley S Samkoe, and William F Hickey, and Ta Yuan Chang
January 2004, Oncology research,
Copied contents to your clipboard!